Published in Langenbecks Arch Surg on October 08, 2015
GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism. Am J Hum Genet (2016) 0.76
Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia. J Clin Res Pediatr Endocrinol (2016) 0.75
Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumour syndrome. Endocr Connect (2017) 0.75
Multigland primary hyperparathyroidism-frequently considered, seldom encountered. Langenbecks Arch Surg (2016) 0.75
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med (2003) 3.07
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab (2012) 2.87
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid (2015) 2.67
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 2.38
Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery (2008) 2.26
Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci U S A (2006) 2.24
Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. J Clin Endocrinol Metab (2009) 2.05
Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg (2006) 1.79
Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab (2006) 1.79
Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg (2012) 1.78
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab (2004) 1.75
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol (2013) 1.71
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab (2000) 1.71
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet (2003) 1.69
Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol (2008) 1.44
Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. Eur J Endocrinol (2012) 1.43
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. J Clin Endocrinol Metab (2007) 1.41
Familial isolated primary hyperparathyroidism due to HRPT2 mutation. Hormones (Athens) (2013) 1.39
The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.36
Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery (1990) 1.34
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) (2008) 1.31
Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) (2002) 1.25
Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest (1994) 1.13
Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med (2005) 1.12
Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab (2004) 1.12
Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf) (2006) 1.11
Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1? Ann Surg (2007) 1.10
Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med (2005) 1.10
Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol (2007) 1.09
Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet (2004) 1.09
Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg (2009) 1.08
Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer (2006) 1.08
Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Pract Res Clin Endocrinol Metab (2013) 1.07
Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res (2002) 1.07
Update multiple endocrine neoplasia type 2. Fam Cancer (2010) 1.06
Familial parathyroid tumors: diagnosis and management. World J Surg (2009) 1.05
Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med (1995) 1.05
p27kip1: a new multiple endocrine neoplasia gene? Neuroendocrinology (2010) 1.04
Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery (1998) 1.04
Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med (1985) 1.03
Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res (2006) 1.01
Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review. Ann Clin Biochem (2004) 1.00
Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol (2004) 1.00
Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res (2002) 1.00
Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery (1992) 1.00
Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg (2008) 0.98
The parathyroid glands in familial hypocalciuric hypercalcemia. Hum Pathol (1981) 0.98
Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery (2003) 0.97
Multiple endocrine neoplasia type 4. Front Horm Res (2013) 0.97
Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group. World J Surg (2001) 0.97
Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch Surg (2009) 0.97
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab (2013) 0.96
Immunohistochemical assessment of parafibromin in mouse and human tissues. J Anat (2006) 0.96
Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.96
Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab (1993) 0.96
Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome. Endocr Relat Cancer (2010) 0.95
Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas. J Clin Endocrinol Metab (2011) 0.94
Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr Relat Cancer (2008) 0.94
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab (2008) 0.94
Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy. Eur J Pediatr (2004) 0.93
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum Mutat (2010) 0.93
Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery (2010) 0.93
Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery (2014) 0.93
Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg (2005) 0.93
Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism. Clin Endocrinol (Oxf) (1999) 0.92
Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr Relat Cancer (2007) 0.92
The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg (2011) 0.92
A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia. J Clin Endocrinol Metab (2009) 0.91
Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family. Genes Chromosomes Cancer (2011) 0.91
Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Horm Cancer (2012) 0.91
Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery (2002) 0.90
Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol (Oxf) (2006) 0.90
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol (2008) 0.90
Hyperparathyroidism-jaw tumor syndrome. Head Neck (2012) 0.89
Hyperparathyroidism-jaw tumor syndrome: a case report. Ann Endocrinol (Paris) (2009) 0.89
Hyperparathyroidism-jaw tumour syndrome detected by aggressive generalized osteitis fibrosa cystica. Clin Cases Miner Bone Metab (2013) 0.89
Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. Br J Surg (2010) 0.89
A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone. Int J Oral Maxillofac Surg (2006) 0.88
Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism. Clin Endocrinol (Oxf) (2012) 0.88
Breast-cancer predisposition in multiple endocrine neoplasia type 1. N Engl J Med (2014) 0.87
Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome. Ann Surg (1981) 0.87
Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg (2001) 0.87
Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: choice of surgical procedure. World J Surg (1986) 0.86
Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol (2006) 0.85
Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism. Surgery (2013) 0.85
The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg (1998) 0.85
Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia). Am J Med (1984) 0.84
A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome. Eur J Endocrinol (2014) 0.84
CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma. J Clin Endocrinol Metab (2014) 0.84
Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery (1996) 0.83
A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab (2004) 0.83
Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding. Eur J Clin Invest (2000) 0.83
Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism. Pediatrics (2012) 0.82
Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg (2005) 0.82
Benign familial hypocalciuric hypercalcemia. Endocr Pract (2011) 0.82
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes. J Intern Med (2009) 0.82